Target Name: ZNF44
NCBI ID: G51710
Review Report on ZNF44 Target / Biomarker Content of Review Report on ZNF44 Target / Biomarker
ZNF44
Other Name(s): Zinc finger protein 44, transcript variant 2 | Zinc finger protein KOX7 | Gonadotropin-inducible ovary transcription repressor 2 | Zinc finger protein 55 | DKFZp686L21136 | Gonadotropin inducible transcription repressor-2 | zinc finger protein 55 | gonadotropin inducible transcription repressor-2 | ZNF504 | ZNF58 | zinc finger protein KOX7 | zinc finger protein ZnFP12 | ZNF44 variant 2 | GIOT-2 | DKFZp434F1811 | ZNF44_HUMAN | gonadotropin-inducible ovary transcription repressor 2 | zinc finger protein 58 | ZNF | KOX7 | Zinc finger protein 58 | zinc finger protein 44 | Zinc finger protein 44 | ZNF55

ZNF44: A Potential Drug Target for Various Diseases

ZNF44, also known as zinc finger protein 44, is a gene that encodes a protein that plays a critical role in cellular signaling. The ZNF44 protein is a transcription factor that is involved in the regulation of gene expression, and it is a key player in the development and maintenance of tissues such as neurons and tissues.

Recent studies have identified ZNF44 as a potential drug target for the treatment of various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. The ZNF44 protein has also been identified as a potential biomarker for the diagnosis and monitoring of these diseases.

One of the key reasons for the potential drug targeting of ZNF44 is its involvement in the regulation of cellular signaling pathways. The ZNF44 protein is a transcription factor that is involved in the regulation of gene expression, and it is a key player in the development and maintenance of tissues such as neurons and tissues.

Studies have shown that the ZNF44 protein plays a critical role in the regulation of cell proliferation, and that it is involved in the development of cancer. In addition, the ZNF44 protein is also involved in the regulation of cell differentiation, and it is a key player in the development of tissues such as neurons and heart tissue.

In addition to its role in cellular signaling, ZNF44 has also been identified as a potential biomarker for the diagnosis and monitoring of various diseases. For example, studies have shown that the ZNF44 protein is involved in the regulation of gene expression in the development of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease.

In addition, the ZNF44 protein has also been identified as a potential drug target for the treatment of these neurodegenerative diseases. Studies have shown that the ZNF44 protein is involved in the regulation of the production of neurotransmitters, which are involved in the transmission of signals in the brain. By targeting the ZNF44 protein, researchers may be able to develop new treatments for neurodegenerative diseases.

Another potential application of ZNF44 as a drug target is its role in the regulation of autoimmune disorders. Studies have shown that the ZNF44 protein is involved in the regulation of immune responses, and that it is a key player in the development of autoimmune disorders.

In addition, the ZNF44 protein has also been identified as a potential biomarker for the diagnosis and monitoring of autoimmune disorders. By targeting the ZNF44 protein, researchers may be able to develop new treatments for autoimmune disorders.

Overall, ZNF44 is a gene that has the potential to be a drug target for the treatment of various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Further research is needed to fully understand the role of ZNF44 in these diseases and to develop new treatments.

Protein Name: Zinc Finger Protein 44

Functions: May be involved in transcriptional regulation

The "ZNF44 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZNF44 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

ZNF440 | ZNF441 | ZNF442 | ZNF443 | ZNF444 | ZNF445 | ZNF446 | ZNF449 | ZNF45 | ZNF451 | ZNF454 | ZNF460 | ZNF461 | ZNF462 | ZNF467 | ZNF468 | ZNF469 | ZNF470 | ZNF471 | ZNF473 | ZNF473CR | ZNF479 | ZNF48 | ZNF480 | ZNF483 | ZNF484 | ZNF485 | ZNF486 | ZNF487 | ZNF488 | ZNF490 | ZNF491 | ZNF492 | ZNF493 | ZNF496 | ZNF497 | ZNF497-AS1 | ZNF500 | ZNF501 | ZNF502 | ZNF503 | ZNF503-AS1 | ZNF503-AS2 | ZNF506 | ZNF507 | ZNF510 | ZNF511 | ZNF512 | ZNF512B | ZNF513 | ZNF514 | ZNF516 | ZNF516-DT | ZNF517 | ZNF518A | ZNF518B | ZNF519 | ZNF519P3 | ZNF521 | ZNF524 | ZNF525 | ZNF526 | ZNF527 | ZNF528 | ZNF528-AS1 | ZNF529 | ZNF529-AS1 | ZNF530 | ZNF532 | ZNF534 | ZNF536 | ZNF540 | ZNF541 | ZNF542P | ZNF543 | ZNF544 | ZNF546 | ZNF547 | ZNF548 | ZNF549 | ZNF550 | ZNF551 | ZNF552 | ZNF554 | ZNF555 | ZNF556 | ZNF557 | ZNF558 | ZNF559 | ZNF559-ZNF177 | ZNF560 | ZNF561 | ZNF561-AS1 | ZNF562 | ZNF563 | ZNF564 | ZNF565 | ZNF566 | ZNF566-AS1 | ZNF567